menu
    • menu

    Find Anlotinib Hydrochloride manufacturers, exporters & distributors on PharmaCompass

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    0

    API Suppliers

    API Suppliers

    0

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    0

    KDMF

    KDMF

    1

    NDC API

    NDC API

    0

    VMF

    NDC API

    0

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 0

    MARKET PLACE

    0

    API

    0

    FDF

    0INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    0

    FDF Dossiers

    FDF Dossiers

    0

    FDA Orange Book

    FDA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    1DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    0

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    NA

    Finished Drug Prices

    NA

    0RELATED EXCIPIENT COMPANIES

    0EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: Anlotinib hcl, 1360460-82-7, Anlotinib hydrochloride, Al3818 dihydrochloride, Catequentinib hydrochloride, Catequentinib dihydrochloride
    Molecular Formula
    C23H24Cl2FN3O3
    Molecular Weight
    480.4  g/mol
    InChI Key
    UUAKQNIPIXQZFN-UHFFFAOYSA-N
    FDA UNII
    A3749M6582
    Anlotinib Hydrochloride
    CATEQUENTINIB HYDROCHLORIDE is a small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication.
    1 2D Structure

    Anlotinib Hydrochloride

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxyquinolin-7-yl]oxymethyl]cyclopropan-1-amine;dihydrochloride
    2.1.2 InChI
    InChI=1S/C23H22FN3O3.2ClH/c1-13-9-15-16(27-13)3-4-19(22(15)24)30-18-5-8-26-17-11-21(20(28-2)10-14(17)18)29-12-23(25)6-7-23;;/h3-5,8-11,27H,6-7,12,25H2,1-2H3;2*1H
    2.1.3 InChI Key
    UUAKQNIPIXQZFN-UHFFFAOYSA-N
    2.2 Other Identifiers
    2.2.1 UNII
    A3749M6582
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Anlotinib Hcl

    2. 1360460-82-7

    3. Anlotinib Hydrochloride

    4. Al3818 Dihydrochloride

    5. Catequentinib Hydrochloride

    6. Catequentinib Dihydrochloride

    7. A3749m6582

    8. 1360460-82-7 (hcl)

    9. 1-[[4-[(4-fluoro-2-methyl-1h-indol-5-yl)oxy]-6-methoxyquinolin-7-yl]oxymethyl]cyclopropan-1-amine;dihydrochloride

    10. Catequentinib Hydrochloride (usan)

    11. Anlotinib 2hcl

    12. 1-(((4-((4-fluoro-2-methyl-1h-indol-5-yl)oxy)-6-methoxyquinolin-7-yl)oxy)methyl)cyclopropan-1-amine Dihydrochloride

    13. 1-[({4-[(4-fluoro-2-methyl-1h-indol-5-yl)oxy]-6-methoxyquinolin-7-yl}oxy)methyl]cyclopropan-1-amine Dihydrochloride

    14. Catequentinib Hydrochloride [usan]

    15. 1-[[[4-[(4-fluoro-2-methyl-1h-indol-5-yl)oxy]-6-methoxy-7-quinolinyl]oxy]methyl]cyclopropanamine Hydrochloride (1:2); Al3818 Dihydrochloride

    16. Chembl5314570

    17. Schembl18691323

    18. Al-3818 Dihydrochloride

    19. Unii-a3749m6582

    20. Bcp19682

    21. Anlotinib (al3818) Dihydrochloride

    22. Hy-19716a

    23. S8726

    24. Ccg-269545

    25. Catequentinib Hydrochloride [who-dd]

    26. Cs-0040093

    27. D12537

    28. D72434

    29. 1-((4-((4-fluoro-2-methyl-1h-indol-5-yl)oxy)-6-methoxy-7-quinolyl)oxymethyl)cyclopropanamine, Dihydrochloride

    30. 1-[[[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-6-methoxyquinolin-7-yl]oxy]methyl]cyclopropanamine Dihydrochloride

    31. Cyclopropanamine, 1-(((4-((4-fluoro-2-methyl-1h-indol-5-yl)oxy)-6-methoxy-7-quinolinyl)oxy)methyl)-, Hydrochloride (1:2)

    32. Cyclopropanamine, 1-[[[4-[(4-fluoro-2-methyl-1h-indol-5-yl)oxy]-6-methoxy-7-quinoliny]oxy]methyl]-, Hydrochloride (1:2)

    2.3.2 Other Synonyms

    1. 1058156-90-3

    2. Anlotinib

    2.4 Create Date
    2012-07-16
    3 Chemical and Physical Properties
    Molecular Weight 480.4 g/mol
    Molecular Formula C23H24Cl2FN3O3
    Hydrogen Bond Donor Count4
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count6
    Exact Mass g/mol
    Monoisotopic Mass g/mol
    Topological Polar Surface Area82.4
    Heavy Atom Count32
    Formal Charge0
    Complexity606
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count3

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Akeso’s Penpulimab Combo for Hepatocellular Cancer Accepted by NMPA in China

    Details:

    AK105 (penpulimab) is a differentiated PD-1 monoclonal antibody, which is being evaluated in combination with Anlotinib HCl for the first-line (1L) treatment of advanced hepatocellular carcinoma.


    Lead Product(s): Penpulimab,Anlotinib Hydrochloride

    Therapeutic Area: Oncology Brand Name: AK105

    Study Phase: Phase IIIProduct Type: Large molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable November 22, 2024

    blank

    01

    Akeso

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Akeso

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Penpulimab,Anlotinib Hydrochloride

    Therapeutic Area : Oncology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Akeso’s Penpulimab Combo for Hepatocellular Cancer Accepted by NMPA in China

    Details : AK105 (penpulimab) is a differentiated PD-1 monoclonal antibody, which is being evaluated in combination with Anlotinib HCl for the first-line (1L) treatment of advanced hepatocellular carcinoma.

    Brand Name : AK105

    Molecule Type : Large molecule

    Upfront Cash : Not Applicable

    November 22, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search